WVE
NASDAQ · Pharmaceuticals
Wave Life Sciences Ltd
$11.76
-0.36 (-2.97%)
Performance
1D
—
1W
—
1M
—
3M
-33.82%
6M
+64.94%
1Y
+17.37%
YTD
-26.27%
Open$12.05
Previous Close$12.12
Day High$12.24
Day Low$11.65
52W High$21.73
52W Low$5.28
Volume—
Avg Volume2.48M
Market Cap2.53B
P/E Ratio—
EPS$-0.74
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$14.99
Below
SMA 200
$9.39
Above
RSI (14)
51.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+428.4% upside
Current
$11.76
$11.76
Target
$62.14
$62.14
$36.97
$62.14 avg
$84.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 147.08M | 106.37M | 444.96M |
| Net Income | -131,740,218 | -85,743,561 | 100.99M |
| Profit Margin | -89.6% | -85.1% | 22.7% |
| EBITDA | -140,266,242 | -96,364,571 | 186.52M |
| Free Cash Flow | — | — | 121.04M |
| Rev Growth | +38.3% | +38.3% | +21.0% |
| Debt/Equity | — | — | 0.53 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |